JOHN BRABANT: Open Payments
NPI 1629448527 · AUBURN HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$749 in 40 payments from 13 companies in 2025. Trend: 2023 $7,766 · 2024 $299 · 2025 $749
Food & beverage: $749
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $242 |
| Otsuka America Pharmaceutical, Inc. | 4 | $101 |
| PFIZER INC. | 4 | $76 |
| ABBVIE INC. | 3 | $64 |
| Exact Sciences Corporation | 3 | $62 |
| Lilly USA, LLC | 3 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| Amgen Inc. | 1 | $19 |
Products named: Rybelsus, REXULTI, NURTEC ODT, Wegovy, Cologuard Collection Kit, MOUNJARO, Kerendia, UBRELVY.
Industry payments across MI — which companies pay providers there.
